Mortality did not decrease, compared with placebo, in patients with chronic obstructive pulmonary disease (COPD) and cardiovascular disease risk who took the inhaled corticosteroid fluticasone furoate ...

Please provide your email address to receive an email when new articles are posted on . Patients with chronic obstructive pulmonary disease treated with a combination of fluticasone furoate and ...

HealthDay News — A combination of fluticasone furoate and vilanterol reduces the rate of moderate or severe exacerbations among patients with chronic obstructive pulmonary disease (COPD), according to ...

Fluticasone furoate/vilanterol (FF/VI) improved FEV1 but did not improve morning peak expiratory flow in pediatric patients with uncontrolled asthma. Among pediatric patients with uncontrolled asthma, ...

Which therapy more effectively reduces severe COPD exacerbations: once-daily FF/UMEC/VI or twice-daily ICS/LABA? Treatment with once-daily single-inhaler fluticasone ...

To assess the safety and efficacy of fluticasone furoate nasal spray (FFNS) compared with placebo for symptomatic relief of uncomplicated ARS. A statistically significant reduction was seen in the ...

Trelegy Ellipta combines fluticasone furoate, an inhaled corticosteroid with umeclidinium, an anticholinergic and vilanterol, a long-acting β2-adrenergic agonist. The Food and Drug Administration (FDA ...

LONDON, Aug. 20, 2014 /PRNewswire/ -- GlaxoSmithKline plc today announced that the FDA has approved Arnuity™ Ellipta ® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS ...

The European Commission has granted marketing approval for fluticasone furoate/vilanterol (FF/VI) (Relvar Ellipta, GlaxoSmithKline and Theravance) for the treatment of asthma and chronic obstructive ...

In a recent article published in the New England Journal of Medicine, researchers presented the findings of an ongoing double-blinded, randomized, placebo-controlled platform-protocol clinical trial, ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using FLUTICASONE FUROATE VIATRIS? FLUTICASONE FUROATE ...

DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Trelegy Ellipta" report has been added to ResearchAndMarkets.com's offering. Trelegy Ellipta ([fluticasone furoate + vilanterol + umeclidinium bromide]; ...